Walcher S - Search Results

1

Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.

Dematteis M, Auriacombe M, D'Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP, Leonardi C, Maremmani I, Torrens M, Walcher S, Soyka M. Dematteis M, et al. Among authors: walcher s. Expert Opin Pharmacother. 2017 Dec;18(18):1987-1999. doi: 10.1080/14656566.2017.1409722. Epub 2017 Dec 3. Expert Opin Pharmacother. 2017. PMID: 29183228 Review.

2

Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE study.

Grebely J, Drolet M, Nwankwo C, Torrens M, Kastelic A, Walcher S, Somaini L, Mulvihill E, Ertl J, Liebert R, Litwin AH. Grebely J, et al. Among authors: walcher s. Int J Drug Policy. 2019 Jan;63:29-38. doi: 10.1016/j.drugpo.2018.10.012. Epub 2018 Nov 23. Int J Drug Policy. 2019. PMID: 30476876

3

Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.

Stöver H, Meroueh F, Marco A, Keppler K, Saiz de la Hoya P, Littlewood R, Wright N, Nava F, Alam F, Walcher S, Somaini L. Stöver H, et al. Among authors: walcher s. BMC Public Health. 2019 Jan 8;19(1):30. doi: 10.1186/s12889-018-6357-x. BMC Public Health. 2019. PMID: 30621658 Free PMC article.

4

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study.

Litwin AH, Drolet M, Nwankwo C, Torrens M, Kastelic A, Walcher S, Somaini L, Mulvihill E, Ertl J, Grebely J. Litwin AH, et al. Among authors: walcher s. J Viral Hepat. 2019 Sep;26(9):1094-1104. doi: 10.1111/jvh.13119. Epub 2019 Jun 11. J Viral Hepat. 2019. PMID: 31074167 Free PMC article.

5

Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder.

Maremmani I, Dematteis M, Gorzelanczyk EJ, Mugelli A, Walcher S, Torrens M. Maremmani I, et al. Among authors: walcher s. J Clin Med. 2023 Aug 26;12(17):5575. doi: 10.3390/jcm12175575. J Clin Med. 2023. PMID: 37685642 Free PMC article.

6

Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.

Beck T, Haasen C, Verthein U, Walcher S, Schuler C, Backmund M, Ruckes C, Reimer J. Beck T, et al. Among authors: walcher s. Addiction. 2014 Apr;109(4):617-26. doi: 10.1111/add.12440. Epub 2014 Jan 19. Addiction. 2014. PMID: 24304412 Free PMC article. Clinical Trial.

7

When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study.

Reimer J, Boniakowski E, Bachner C, Weber B, Tietje W, Verthein U, Walcher S. Reimer J, et al. Among authors: walcher s. Subst Abuse Treat Prev Policy. 2014 Feb 28;9:13. doi: 10.1186/1747-597X-9-13. Subst Abuse Treat Prev Policy. 2014. PMID: 24581310 Free PMC article.

8

High Concomitant Misuse of Fentanyl in Subjects on Opioid Maintenance Treatment.

Krause D, Plörer D, Koller G, Martin G, Winter C, Adam R, Canolli M, Al-Iassin J, Musselmann R, Walcher S, Schäfer F, Pogarell O. Krause D, et al. Among authors: walcher s. Subst Use Misuse. 2017 Apr 16;52(5):639-645. doi: 10.1080/10826084.2016.1246571. Epub 2017 Feb 3. Subst Use Misuse. 2017. PMID: 28157415

9

The opiate dosage adequacy scale for identification of the right methadone dose--a prospective cohort study.

Walcher S, Koc J, Reichel V, Schlote F, Verthein U, Reimer J. Walcher S, et al. BMC Pharmacol Toxicol. 2016 Apr 7;17:15. doi: 10.1186/s40360-016-0058-9. BMC Pharmacol Toxicol. 2016. PMID: 27052201 Free PMC article.

10

Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine.

Lehmann K, Kuhn S, Baschirotto C, Jacobsen B, Walcher S, Görne H, Backmund M, Scherbaum N, Reimer J, Verthein U. Lehmann K, et al. Among authors: walcher s. J Subst Abuse Treat. 2021 Aug;127:108350. doi: 10.1016/j.jsat.2021.108350. Epub 2021 Mar 4. J Subst Abuse Treat. 2021. PMID: 34134867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page